SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Gritstone bio, Inc. (GRTS) .
本页证实的标准:
- VALUE (100/100, 通过) — 分析师目标价暗示上行空间 (+14403.1%).
- 分析师共识目标价 $4.67 (+14403.1% 上行空间) — 华尔街分析师认为存在显著上行潜力。
SharesGrow 综合评分： 40/100 其中 2/7 项标准通过。
SharesGrow 7-Criteria Score
✓
价值
100/100
Price-to-Earnings & upside
Proven by this page
✗
健康
33/100
Debt-to-Equity & liquidity
→ Health
估值概览 — GRTS
估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率2.79
EV/EBITDA0.0
每股数据
EPS (TTM)$-1.20
每股账面价值$0.00
每股营收$0.01
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%
分析师目标价$4.67 (+14403.1%)
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2016 |
$-0.93 |
$0.00 |
$-18.75M |
- |
| 2017 |
$-2.06 |
$0.00 |
$-41.38M |
- |
| 2018 |
$-7.26 |
$1.19M |
$-64.78M |
-5457% |
| 2019 |
$-2.71 |
$4.37M |
$-90.93M |
-2083.1% |
| 2020 |
$-2.77 |
$4.04M |
$-104.61M |
-2591.3% |
| 2021 |
$-0.95 |
$46.72M |
$-74.96M |
-160.4% |
| 2022 |
$-1.24 |
$9.27M |
$-113.13M |
-1220.5% |
| 2023 |
$-1.20 |
$1.33M |
$-138.49M |
-10405% |
